These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 15554761

  • 1. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
    Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, Josiassen RC.
    J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.
    Halbreich U, Kinon BJ, Gilmore JA, Kahn LS.
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():53-67. PubMed ID: 12504072
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications.
    Alosaimi FD, Fallata EO, Abalhassan M, Alhabbad A, Alzain N, Alhaddad B, Alassiry MZ.
    Int J Psychiatry Clin Pract; 2018 Nov; 22(4):274-281. PubMed ID: 29334291
    [Abstract] [Full Text] [Related]

  • 10. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML, Shen WW, Chen CH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1978-81. PubMed ID: 18848860
    [Abstract] [Full Text] [Related]

  • 11. Risperidone added to clozapine: impact on serum prolactin levels.
    Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D.
    J Clin Psychiatry; 2001 Aug 12; 62(8):605-8. PubMed ID: 11561931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation between Prolactin and Symptom Profile in Acute Admitted Women with Recurrent Schizophrenia.
    Herceg M, Puljić K, Jambrošić Sakoman A, Sušac J, Todorić Laidlaw I, Herceg D, Sisek-Šprem M.
    Psychiatr Danub; 2020 Aug 12; 32(3-4):367-372. PubMed ID: 33370734
    [Abstract] [Full Text] [Related]

  • 15. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M, Terao T, Iwata N, Nakamura J.
    Pharmacopsychiatry; 2005 Jan 12; 38(1):17-9. PubMed ID: 15706461
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.
    Gopal S, Lane R, Nuamah I, Copenhaver M, Singh J, Hough D, Bach M, Savitz A.
    CNS Drugs; 2017 Sep 12; 31(9):797-808. PubMed ID: 28660406
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A.
    Int Clin Psychopharmacol; 2007 Jul 12; 22(4):192-6. PubMed ID: 17519641
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.